This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cross, M.
Right arrow Articles by Borst, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cross, M.
Right arrow Articles by Borst, P.

 Previous Article  |  Next Article 

Mol. Cell. Biol., Jan 1998, 198-205, Vol 18, No. 1
Copyright © 1998, American Society for Microbiology

Frequent loss of the active site during variant surface glycoprotein expression site switching in vitro in Trypanosoma brucei

M Cross, MC Taylor and P Borst
Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam.

African trypanosomes undergo antigenic variation of their variant surface glycoprotein (VSG) coat to avoid being killed by their mammalian hosts. The active VSG gene is located in one of many telomeric expression sites. Replacement of the VSG gene in the active site or switching between expression sites can give rise to a new VSG coat. To study Trypanosoma brucei VSG expression site inactivation rather than VSG gene switching, it is useful to have an in vitro negative-selection system independent of the VSG. We have achieved this aim by using a viral thymidine kinase (TK) gene. Following integration of the TK gene downstream of the 221a VSG expression site promoter, transformant cell lines became sensitive to the nucleoside analog 1-(2- deoxy-2-fluoro-8-D-arabinofuranosyl)-5-iodouracil. These TK trypanosomes were able to revert to resistance at a rate approaching 10(-5) per cell per generation. The majority of revertants expressed a new VSG gene even though there had been no selection against the VSG itself. Analysis of these switched variants showed that some had shut down TK expression via an in situ expression site switch. However, most variants had the complete 221 expression site deleted and another VSG expression site activated. We speculate that a new VSG expression site cannot switch on without inactivation of the old site.


This article has been cited by other articles:

  • Proudfoot, C., McCulloch, R. (2005). Distinct roles for two RAD51-related genes in Trypanosoma brucei antigenic variation. Nucleic Acids Res 33: 6906-6919 [Abstract] [Full Text]  
  • McCulloch, R., Barry, J. D. (1999). A role for RAD51 and homologous recombination in Trypanosoma brucei antigenic variation. Genes Dev. 13: 2875-2888 [Abstract] [Full Text]  
  • van Leeuwen, F., Kieft, R., Cross, M., Borst, P. (1998). Biosynthesis and Function of the Modified DNA Base beta -D-Glucosyl-Hydroxymethyluracil in Trypanosoma brucei. Mol. Cell. Biol. 18: 5643-5651 [Abstract] [Full Text]